Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

GMSI Award 2015 – Introduction and Welcome

David Bates


This lecture was given at the GMSI Award Event, 8th October 2015. The GMSI award was supported by Merck KGaA, Darmstadt, Germany.

Professor Bates is in the Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

Professor Bates said that the GMSI [Grant for Multiple Sclerosis Innovation] was first awarded in 2013. Merck Serono provides research grants of up to 1 million Euros and thereby demonstrated its commitment to immunology in general and multiple sclerosis in particular. The projects are translational research, largely by academic researchers. An attempt is made to apply the following criteria. The main criterion is that the research should improve understanding of multiple sclerosis for the benefit of patients, their relatives and carers. It should provide some more knowledge of pathogenesis. It would be desirable to have evidence of predictive markers of treatment response and disease progress. Potential new treatments are desirable, as would be more information about  the various subtypes of multiple sclerosis.

Professor Bates introduced Steven Hildemann, who is Professor at Freiburg University and the Global Chief Medical Officer of Merck Serono. Professor Hildemann had been interested in the GMSI since its inception. He would give an update and introduce the four current award winners, who would explain the topics they plan to study.

Related content